InMed Pharmaceuticals Announces Proposed 1-for-10 Reverse Stock Split
InMed Pharmaceuticals (INM) has announced a proposed 1-for-10 reverse share consolidation. This move is contingent upon the approval of three merger-related proposals scheduled for discussion at the company's annual general and special meeting on November 4, 2026. The consolidation is a strategic component of a planned merger and reorganization involving Mentari Therapeutics. If approved, the total outstanding common shares will decrease from approximately 5.49 million to roughly 549,374 on a non-diluted basis prior to the merger's completion.
Tickers: $INM
Topics: merger reorganization reverse share split share consolidation
Read the full article at Seeking Alpha
Part of the story ReTo Eco-Solutions Announces Eight-to-One Reverse Stock Split (7 articles)